Skip to content
Recall Observatory FDA recall evidence

Drug product

Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count bottles (NDC 0378-1807-10), Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A.

D-0126-2025

November 18, 2024

Class II

Product summary

Firm
Viatris Inc
Event
Event 95768
Status
Ongoing
Classification
Class II
Quantity
43,765 bottles
Official record key
drug-enforcement:D-0126-2025

Official wording

Reason: Superpotent Drug and Subpotent Drug: potency failures obtained

Code information: Lot # a) 8180781, Exp. Date Aug 2025; b)3191628, Exp. Date Feb 2025; 3197139, Exp. Date Apr 2025; 3188976, Exp. Date Jan 2025; 3184929, Exp. Date Dec 2024; 3204909, Exp. Date Aug 2025

Distribution pattern: Nationwide within the United States and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Superpotent